Updates on LI-RADS Treatment Response Criteria for Hepatocellular Carcinoma: Focusing on MRI

J Magn Reson Imaging. 2023 Jun;57(6):1641-1654. doi: 10.1002/jmri.28659. Epub 2023 Mar 5.

Abstract

As the incidence of hepatocellular carcinoma (HCC) and subsequent treatments with liver-directed therapies rise, the complexity of assessing lesion response has also increased. The Liver Imaging Reporting and Data Systems (LI-RADS) treatment response algorithm (LI-RADS TRA) was created to standardize the assessment of response after locoregional therapy (LRT) on contrast-enhanced CT or MRI. Originally created based on expert opinion, these guidelines are currently undergoing revision based on emerging evidence. While many studies support the use of LR-TRA for evaluation of HCC response after thermal ablation and intra-arterial embolic therapy, data suggest a need for refinements to improve assessment after radiation therapy. In this manuscript, we review expected MR imaging findings after different forms of LRT, clarify how to apply the current LI-RADS TRA by type of LRT, explore emerging literature on LI-RADS TRA, and highlight future updates to the algorithm. EVIDENCE LEVEL: 3. TECHNICAL EFFICACY: Stage 2.

Keywords: Liver Imaging Data and Reporting System treatment response algorithm; hepatocellular carcinoma; locoregional therapy; treatment response assessment.

Publication types

  • Review
  • Research Support, N.I.H., Extramural

MeSH terms

  • Carcinoma, Hepatocellular* / diagnostic imaging
  • Carcinoma, Hepatocellular* / radiotherapy
  • Contrast Media
  • Data Systems
  • Humans
  • Liver Neoplasms* / diagnostic imaging
  • Liver Neoplasms* / radiotherapy
  • Magnetic Resonance Imaging / methods
  • Retrospective Studies
  • Sensitivity and Specificity

Substances

  • Contrast Media